Is My Parkinson’s Honeymoon Over?
Feb 11, 2020 09:00 am | Jean Mellano
 When I started writing this column, I was having a pity party and was in a bad place. Wanting to reflect positivity, I decided to stop writing until I had a better frame of mind. Why was I feeling sorry for myself? More than four years have passed since my Parkinson’s diagnosis. I didn’t realize […]
The post Is My Parkinson’s Honeymoon Over? appeared first on Parkinson's News Today. |
Palliative care — focusing on physical, psychosocial and spiritual treatment — for people with Parkinson’s disease and related disorders (PDRD) led to a significantly better quality of life (QoL) than standard care alone, a study finds. Easing of both non-motor and motor symptom severity was linked to palliative care intervention — and those with the […]
Last week I had surgery. Little did I know that it would be a great time to advocate for Parkinson’s disease (PD). It began with the registration process two days before my hospital check-in. The hospital’s admittance clerk called me with some last-minute instructions for my surgery, which took place two days after the phone call […]
Activated immune T-cells can infiltrate the brain and promote neurodegeneration in non-human primate models of Parkinson’s during the chronic stages of the disease, a study has found. Results of the study, “Chronic infiltration of T lymphocytes into the brain in a non-human primate model of Parkinson’s disease,” were published in the journal Neuroscience. Parkinson’s disease is […]
Genetic variations in the gene apolipoprotein E (APOE) alter the dynamics of alpha-synuclein protein buildup in the brains of mice with Parkinson’s disease (PD), according to a new study. This suggests suggests that alterations in APOE could affect the occurrence of dementia in humans with the neurodegenerative disease, the researchers said. Titled “APOE genotype regulates […]
The U.S. Food and Drug Administration (FDA) has granted breakthrough device designation to nQ Medical’s neuroQUERTY software, which is designed to monitor brain health and Parkinson’s disease progression. Breakthrough device status is given to medical devices that have the potential to be an effective treatment or diagnostic tool for life-threatening or irreversibly debilitating diseases. The status […]
